FSN E-Commerce Ventures Limited (BOM:543384)
India · Delayed Price · Currency is INR 208.85
-2.40 (-1.14%)
At close: Aug 6, 2025
Oncternal Therapeutics Revenue
In the fiscal year ending March 31, 2025, FSN E-Commerce Ventures had annual revenue of 79.50B INR with 24.50% growth. FSN E-Commerce Ventures had revenue of 20.62B in the quarter ending March 31, 2025, with 23.61% growth.
Revenue
79.50B
Revenue Growth
+24.50%
P/S Ratio
7.27
Revenue / Employee
40.13M
Employees
1,669
Market Cap
578.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 79.50B | 15.64B | 24.50% |
| Mar 31, 2024 | 63.86B | 12.42B | 24.14% |
| Mar 31, 2023 | 51.44B | 13.70B | 36.30% |
| Mar 31, 2022 | 37.74B | 13.33B | 54.61% |
| Mar 31, 2021 | 24.41B | 6.73B | 38.10% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Hindustan Unilever | 639.28B |
| Infosys | 1,672.76B |